UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing Therapies

Clinical therapeutics, 2023-11, Vol.45 (11), p.1034-1046

2023

Volltextzugriff (PDF)

Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism

Circulation (New York, N.Y.), 2017-01, Vol.135 (4), p.338-351

2017

Volltextzugriff (PDF)

Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2023/03/01, Vol.30(3), pp.274-286

2023

Volltextzugriff (PDF)

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

Clinical science (1979), 2008-05, Vol.114 (10), p.611-624

2008

Volltextzugriff (PDF)

Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care

Frontiers in genetics, 2022-04, Vol.13, p.905941-905941

2022

Volltextzugriff (PDF)

A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia

The journal of clinical endocrinology and metabolism, 2018-04, Vol.103 (4), p.1704-1714

2018

Volltextzugriff (PDF)

New Insights Into the Regulation of Lipoprotein Metabolism by PCSK9: Lessons From Stable Isotope Tracer Studies in Human Subjects

Frontiers in physiology, 2021-02, Vol.12, p.603910-603910

2021

Volltextzugriff (PDF)

Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease

Journal of the American Heart Association, 2020-03, Vol.9 (6), p.e015355

2020

Volltextzugriff (PDF)

Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

Diabetes care, 2010-05, Vol.33 (5), p.1134-1139

2010

Volltextzugriff (PDF)

Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical Experience

Pharmaceuticals (Basel, Switzerland), 2022-11, Vol.15 (11), p.1389

2022

Volltextzugriff (PDF)

RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study

Clinical and translational medicine, 2023-11, Vol.13 (11), p.e1484-n/a

2023

Volltextzugriff (PDF)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy

Journal of the American Heart Association, 2019-04, Vol.8 (7), p.e011781

2019

Volltextzugriff (PDF)

Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome

The journal of clinical endocrinology and metabolism, 2014-11, Vol.99 (11), p.E2335-E2340

2014

Volltextzugriff (PDF)

Lipoprotein(a) Is Associated with Thrombus Burden in Culprit Arteries of Younger Patients with ST-Segment Elevation Myocardial Infarction

Cardiology, 2023-06, Vol.148 (2), p.98-102

2023

Volltextzugriff (PDF)

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions

Journal of clinical lipidology, 2016-11, Vol.10 (6), p.1329-1337.e3

2016

Volltextzugriff (PDF)

Plasma Proprotein Convertase Subtilisin/Kexin Type 9 as a Predictor of Carotid Atherosclerosis in Asymptomatic Adults

Heart, lung & circulation, 2016-05, Vol.25 (5), p.520-525

2016

Volltextzugriff (PDF)

Is type 2 diabetes associated dementia a microvascular early-Alzheimer's phenotype induced by aberrations in the peripheral metabolism of lipoprotein-amyloid?

Frontiers in endocrinology (Lausanne), 2023-02, Vol.14, p.1127481-1127481

2023

Volltextzugriff (PDF)

Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state

Clinical science (1979), 2015-03, Vol.128 (6), p.379-385

2015

Volltextzugriff (PDF)

The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia

Baillière's best practice & research. Clinical endocrinology & metabolism, 2014-06, Vol.28 (3), p.369-385

2014

Volltextzugriff (PDF)

Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”

Journal of clinical lipidology, 2019-03, Vol.13 (2), p.287-300

2019

Volltextzugriff (PDF)

Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III

Journal of lipid research, 2009-12, Vol.50 (12), p.2524-2531

2009

Volltextzugriff (PDF)

Recent advances in demystifying the metabolism of lipoprotein(a)

Atherosclerosis, 2022-05, Vol.349, p.82-91

2022

Volltextzugriff (PDF)

Cascade testing for elevated lipoprotein(a) in relatives of probands with high lipoprotein(a)

American journal of preventive cardiology, 2022-06, Vol.10, p.100343, Article 100343

2022

Volltextzugriff (PDF)

Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box

Metabolism, clinical and experimental, 2012, Vol.61 (1), p.3-11

2012

Volltextzugriff (PDF)

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

Journal of lipid research, 2011-04, Vol.52 (4), p.794-800

2011

Volltextzugriff (PDF)

1 – 25 von 286

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(268)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Englisch
(286)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Promise of PCSK9 and Lipoprotein(a) as Targets for Gene Silencing Therapies

Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism

Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care

A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia

New Insights Into the Regulation of Lipoprotein Metabolism by PCSK9: Lessons From Stable Isotope Tracer Studies in Human Subjects

Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease

Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical Experience

RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering Therapy

Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome

Lipoprotein(a) Is Associated with Thrombus Burden in Culprit Arteries of Younger Patients with ST-Segment Elevation Myocardial Infarction

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions

Plasma Proprotein Convertase Subtilisin/Kexin Type 9 as a Predictor of Carotid Atherosclerosis in Asymptomatic Adults

Is type 2 diabetes associated dementia a microvascular early-Alzheimer's phenotype induced by aberrations in the peripheral metabolism of lipoprotein-amyloid?

Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state

The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia

Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”

Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III

Recent advances in demystifying the metabolism of lipoprotein(a)

Cascade testing for elevated lipoprotein(a) in relatives of probands with high lipoprotein(a)

Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

Suchergebnisse filtern